Jim Moselhy

414 total citations
11 papers, 322 citations indexed

About

Jim Moselhy is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Jim Moselhy has authored 11 papers receiving a total of 322 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Oncology and 2 papers in Organic Chemistry. Recurrent topics in Jim Moselhy's work include Hydrogels: synthesis, properties, applications (2 papers), Advanced Polymer Synthesis and Characterization (2 papers) and Phytochemicals and Medicinal Plants (2 papers). Jim Moselhy is often cited by papers focused on Hydrogels: synthesis, properties, applications (2 papers), Advanced Polymer Synthesis and Characterization (2 papers) and Phytochemicals and Medicinal Plants (2 papers). Jim Moselhy collaborates with scholars based in United States, Canada and Australia. Jim Moselhy's co-authors include Xiao Yu Wu, Chendil Damodaran, Murali K. Ankem, Sowmyalakshmi Srinivasan, Cheryl L. Jorcyk, Houda Alatassi, Pilar Aranda, Jeffrey D. Redshaw, Suman Suman and C A Bolin and has published in prestigious journals such as Macromolecules, Oncotarget and International Journal of Nanomedicine.

In The Last Decade

Jim Moselhy

11 papers receiving 308 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jim Moselhy United States 10 104 96 47 45 40 11 322
Evangelia Sereti Greece 10 150 1.4× 68 0.7× 36 0.8× 26 0.6× 95 2.4× 14 327
Kai Dong China 15 176 1.7× 57 0.6× 89 1.9× 18 0.4× 77 1.9× 32 527
Niloufar Rahiman Iran 9 113 1.1× 84 0.9× 44 0.9× 17 0.4× 87 2.2× 21 341
Mohammad A. Abdulkader United Kingdom 9 74 0.7× 65 0.7× 16 0.3× 15 0.3× 56 1.4× 16 314
Fushan Tang China 13 177 1.7× 65 0.7× 63 1.3× 29 0.6× 199 5.0× 40 515
Zhe Yu China 12 101 1.0× 93 1.0× 20 0.4× 11 0.2× 75 1.9× 25 357
Geanina Voicu Romania 10 127 1.2× 36 0.4× 26 0.6× 12 0.3× 63 1.6× 24 375
Boyu Du China 11 193 1.9× 76 0.8× 87 1.9× 8 0.2× 25 0.6× 28 486
Nirnoy Dan United States 7 139 1.3× 67 0.7× 39 0.8× 9 0.2× 116 2.9× 9 376

Countries citing papers authored by Jim Moselhy

Since Specialization
Citations

This map shows the geographic impact of Jim Moselhy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jim Moselhy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jim Moselhy more than expected).

Fields of papers citing papers by Jim Moselhy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jim Moselhy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jim Moselhy. The network helps show where Jim Moselhy may publish in the future.

Co-authorship network of co-authors of Jim Moselhy

This figure shows the co-authorship network connecting the top 25 collaborators of Jim Moselhy. A scholar is included among the top collaborators of Jim Moselhy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jim Moselhy. Jim Moselhy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Moselhy, Jim, Suman Suman, Mohammed Alghamdi, et al.. (2017). Withaferin A Inhibits Prostate Carcinogenesis in a PTEN-deficient Mouse Model of Prostate Cancer. Neoplasia. 19(6). 451–459. 28 indexed citations
2.
Suman, Suman, Trinath P. Das, Jim Moselhy, et al.. (2016). Oral administration of withaferin A inhibits carcinogenesis of prostate in TRAMP model. Oncotarget. 7(33). 53751–53761. 32 indexed citations
3.
Moselhy, Jim, Sowmyalakshmi Srinivasan, Murali K. Ankem, & Chendil Damodaran. (2015). Natural Products That Target Cancer Stem Cells.. PubMed. 35(11). 5773–88. 46 indexed citations
4.
Bolin, Celeste, et al.. (2012). Novel mouse mammary cell lines for in vivo bioluminescence imaging (BLI) of bone metastasis. Biological Procedures Online. 14(1). 6–6. 17 indexed citations
5.
Bolin, C A, Jeffrey D. Redshaw, Pilar Aranda, et al.. (2012). Oncostatin M Promotes Mammary Tumor Metastasis to Bone and Osteolytic Bone Degradation. Genes & Cancer. 3(2). 117–130. 62 indexed citations
7.
Moselhy, Jim, et al.. (2007). Evaluation of copolymers of N-isopropylacrylamide and 2-dimethyl(aminoethyl)methacrylate in nonviral and adenoviral vectors for gene delivery to nasopharyngeal carcinoma.. PubMed. 2(3). 461–78. 12 indexed citations
8.
Liu, Jiang, Ho-Lun Wong, Jim Moselhy, et al.. (2006). Targeting colloidal particulates to thoracic lymph nodes. Lung Cancer. 51(3). 377–386. 40 indexed citations
9.
Liu, Jiang, Ho-Lun Wong, Jim Moselhy, et al.. (2006). Targeting colloidal particulates to thoracic lymph nodes. Lung Cancer. 6 indexed citations
10.
Moselhy, Jim, et al.. (2000). In vitro studies of the interaction of poly(NIPAm/MAA) nanoparticles with proteins and cells. Journal of Biomaterials Science Polymer Edition. 11(2). 123–147. 50 indexed citations
11.
Ni, Shaoru, Didier Juhué, Jim Moselhy, Yongcai Wang, & Mitchell A. Winnik. (1992). Energy-transfer studies of donor-acceptor-labeled polystyrene-block-poly(methyl methacrylate) diblock copolymers in solution. Macromolecules. 25(1). 496–498. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026